Actuate Therapeutics ACTU
NASDAQ ACTU
$0.82 -0.07 (-7.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Other Accumulated Expenses (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) reported Other Accumulated Expenses of $2.3 million for Q2 2026, down 49.6% from $4.57 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics posted Other Accumulated Expenses of $3.57 million, down 39.8% from FY2024.

  • By year, Other Accumulated Expenses came in at $5.92 million in FY2024 (+83.8%) and $3.22 million in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Other Accumulated Expenses in data going back to Q4 2023.
  • Year over year, Other Accumulated Expenses gained in 1 of the last five quarters, with an average decline of 13.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Actuate Therapeutics 19.69 Mn 19.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.30 Mn
Dec 31, 2025 3.57 Mn
Sep 30, 2025 4.26 Mn
Jun 30, 2025 4.57 Mn
Mar 31, 2025 5.20 Mn
Dec 31, 2024 5.92 Mn
Sep 30, 2024 6.10 Mn
Jun 30, 2024 6.93 Mn
Dec 31, 2023 3.22 Mn
API Access

Actuate Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACTU&period=max&api_key=YOUR_API_KEY